 | • レポートコード：MRC2303I0194 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の超低温冷凍庫市場規模が、予測期間中（2022年-2027年）に年平均3.9%で成長すると予測しています。本書では、超低温冷凍庫の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品タイプ別（直立型、チェスト型）分析、エンドユーザー別（バイオバンク、製薬＆バイオ技術企業、学術＆研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、Thermo Fisher Scientific, Inc、PHC Holdings Corporation、Haier Biomedical、Arctiko A/S、Helmer Scientific、Eppendorf AG、Abzil Telstar S.L、Labcold Ltd、Bionics Scientific Technologies （P） Ltd、Global Cooling, Incなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の超低温冷凍庫市場規模：製品タイプ別 - 直立型超低温冷凍庫の市場規模 - チェスト型超低温冷凍庫の市場規模 ・世界の超低温冷凍庫市場規模：エンドユーザー別 - バイオバンクにおける市場規模 - 製薬＆バイオ技術企業における市場規模 - 学術＆研究所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の超低温冷凍庫市場規模：地域別 - 北米の超低温冷凍庫市場規模 アメリカの超低温冷凍庫市場規模 カナダの超低温冷凍庫市場規模 メキシコの超低温冷凍庫市場規模 … - ヨーロッパの超低温冷凍庫市場規模 ドイツの超低温冷凍庫市場規模 イギリスの超低温冷凍庫市場規模 フランスの超低温冷凍庫市場規模 … - アジア太平洋の超低温冷凍庫市場規模 中国の超低温冷凍庫市場規模 インドの超低温冷凍庫市場規模 日本の超低温冷凍庫市場規模 … - 中東・アフリカの超低温冷凍庫市場規模 GCC諸国の超低温冷凍庫市場規模 南アフリカの超低温冷凍庫市場規模 … - 南米の超低温冷凍庫市場規模 ブラジルの超低温冷凍庫市場規模 アルゼンチンの超低温冷凍庫市場規模 … - その他地域の超低温冷凍庫市場規模 ・競争状況 ・市場機会・将来の動向 |
The Ultra-Low Temperature Freezers Market is expected to witness a CAGR of 3.9% during the forecast period (2022-2027).
The impact of COVID-19 on the market’s growth was substantial as ultra-low temperature freezers played a crucial role in the storage and distribution of large amounts of COVID-19 vaccinations that required ultra-cold conditions. According to the World Health Organization data, in September 2021, vaccine storage capacity increased to nine million due to ultra-low temperature freezers. This increased ultra-cold chain capacity allowed COVAX, the vaccine pillar of the Access to COVID-19 Tools (ACT) Accelerator, to ship 2.5 million Pfizer-donated doses from the United States. Moreover, growing strategic developments and product launches with respect to ultra-low temperature freezers amid the pandemic have boosted the market’s growth. For instance, in January 2021, Telstar’s Boreas ultra-low-temperature freezers were designed to store COVID-19 vaccinations at -86°C. The freezers have vacuum panels for high degrees of insulation, allowing them to maintain a temperature of -80°C with ambient temperatures as high as +28°C. Thus, COVID-19 has had a significant impact on the growth of the market.
Moreover, rising infectious diseases, cancer, and other chronic diseases have led to new drug discoveries and development, stimulating demand for ultra-low temperature freezers (ULTF). Demand for ultra-low temperature freezers is particularly high in research and development and in biobanks for storing and transporting drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples.
Additionally, in June 2021, Thermo Fisher Scientific launched the TSX Series Ultra-Low Temperature (ULT) to deliver environmentally sustainable protection of materials such as vaccines, cell culture media, biologics, and reagents. Furthermore, in December 2021, BioLife Solutions, Inc. signed a partnership agreement with UNICEF to extend the thermal stability of temperature-sensitive COVID-19 vaccines in developing communities in Africa, the Middle East, and South America. As part of this program, UNICEF has approved Stirling’s upright SU780XLE freezers and first-of-its-kind, portable UL25NEU freezer models for country-specific selection.
Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, high costs associated with ultra-low temperature freezers and stringent regulatory issues regarding ultra-low temperature freezers may hinder the growth of the market.
Ultra Low Temperature Freezers Market Trends
Upright Ultra-Low Temperature Freezers Segment is Expected to Hold a Major Market Share
The upright ULT freezer enables quick cooling after opening, simple access, and individually customizable inner compartments for regular usage. However, less used items can be stored in a chest ULT freezer safely for an extended period of time that allows the usage of the chest ULT for specific purposes. Upright ultra-low temperature freezers (ULT freezers) typically have a temperature range of -40°C to -86°C and are used to store drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples. Such advantages offered by upright ULTs are anticipated to boost the adoption of these freezers in the near future.
Moreover, the segment’s growth is driven by a surge in research and development activities for pharmaceutical drugs and vaccines. Several medicines under clinical trial are expected to be launched over the coming years that may require ultra-cold conditions for storage and transportation of raw materials. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2021, 2,178 are in Phase III trials, and 3,752 are in Phase II trials in 2020. Thus, the demand for the upright ultra-low temperature freezer segment is expected to grow over the forecast period.
Thus, all the above factors are expected to increase demand for upright ultra-low temperature freezers, thereby boosting the segment’s growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
North America is expected to hold a significant market share in the global ultra-low temperature freezers market due to the presence of several biobanks, pharmaceutical and biotechnology companies within the region. The region is estimated to hold a substantial share of the global ultra-low temperature freezers market, and the trend is projected to continue during the forecast period.
Moreover, the COVID-19 outbreak is anticipated to drive the ultra-low temperature freezer market over the forecast period in the region owing to an increase in research and development activities for COVID-19 vaccines. For example, the BINDER CO2 freezer is helping scientists retain coronavirus samples during research.
Furthermore, the high adoption of technologically advanced ultra-low temperature freezers and product launches is expected to propel the growth of the overall regional market. For instance, in May 2020, Thermo Fisher Scientific launched a new service that collects and tracks crucial performance data from the linked TSX Series ULT freezers to ensure the safety of samples and products. Thermo Scientific’s intelligent connected systems function keeps track of 37 types of alarms and 26 operating metrics, enabling the user to examine the linked TSX Series ULT freezers thoroughly.
Thus, all the factors mentioned above are expected to increase demand for ultra-low temperature freezers and boost market growth over the forecast period.
Ultra Low Temperature Freezers Market Competitor Analysis
The market studied is moderately competitive, and several companies are operating in this market. Some of the major players operating in the market include Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Haier Biomedical, Arctiko A/S, Helmer Scientific, Eppendorf AG, Abzil Telstar S.L, Labcold Ltd., Bionics Scientific Technologies (P) Ltd., and Global Cooling, Inc., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Applications in Bio-Banks, Drug Discovery and life-Sciences Research
4.2.2 Technological Advancement in Ultra-Low Temperature Freezers
4.3 Market Restraints
4.3.1 High Costs Associated with Ultra-Low Temperature Freezers
4.3.2 Stringent Regulatory Issues Regarding Ultra-Low Temperature Freezers
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product Type
5.1.1 Upright ULT freezers
5.1.2 Chest ULT freezers
5.2 By End User
5.2.1 Bio-Banks
5.2.2 Pharmaceutical and Biotechnology Companies
5.2.3 Academic and Research Laboratories
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific, Inc
6.1.2 PHC Holdings Corporation
6.1.3 Haier Biomedical
6.1.4 Arctiko A/S
6.1.5 Helmer Scientific
6.1.6 Eppendorf AG
6.1.7 Abzil Telstar S.L
6.1.8 Labcold Ltd
6.1.9 Bionics Scientific Technologies (P) Ltd
6.1.10 Global Cooling, Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
